Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gold (chrysotherapy)

3

XV.a Path: NSIP-cellular pattern (see also Ia, Ib)

2
Last update : 20/09/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Aurothiopropanosulfonate
3

Publications

Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.
American journal of respiratory and critical care medicine 1997 Mar;155;1011-20 1997 Mar
Gold pulmonary toxicity in a patient with a normal chest radiograph.
Southern medical journal 1995 Jun;88;644-6 1995 Jun
Gold lung.
British medical journal 1978 Jun 10;1;1523-4 1978 Jun 10
Diffuse pulmonary injury associated with gold treatment.
The New England journal of medicine 1976 Apr 22;294;919-21 1976 Apr 22

Powered by

  • ^
  • Contact
  • Cookies
  • About